Improving the success rate of engineering RNA viruses

Improving the success rate of engineering RNA viruses

In our previous post on this topic, we introduced the details on how to make a replicating RNA virus from its genome (DNA). In this post, we want to zoom in on the details a bit more and share how we have improved the success rate of engineering viruses to over 70%. If you have not read the previous post on the science of viral engineering and want to get a first level understanding on how the process works, go…

Announcing our first publication

Announcing our first publication

We are thrilled to announce the publication of Humane Genomics’ first article. We contributed a chapter to the International Review of Cell and Molecular Biology (IRCMB). This is a book series by Elsevier, as part of a special issue on Viral Vectors in Cancer Immunotherapy. Our review, titled “Rational selection of an ideal oncolytic virus to address current limitations in clinical translation,” offers valuable insights for investors, virologists, and newcomers to the field alike. In our article, we summarize the…

Presenting at AACR

Presenting at AACR

We are excited to announce we are presenting at the AACR annual meeting for the first time. AACR is the American Association for Cancer Research and its meeting is the largest in the world of cancer research. Last year, over 20,000 scientists, clinicians and other health care professionals, and survivors and patient advocates from around the world traveled to New Orleans. The AACR meeting for 2023 is held in Orange County Convention Center, Orlando, Florida and we have been invited…